CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders

Area of Science:

• Immunology
• Cell Biology

Background:

• CD20 is typically a B cell marker, but its presence on other immune cells is increasingly recognized.
• Understanding CD20 expression beyond B cells is crucial for immune system research.

Purpose of the Study:

• To identify and characterize a novel CD20-expressing Natural Killer (NK) cell population.
• To investigate the functional significance and molecular signature of these CD20+ NK cells.

Main Methods:

• Flow cytometry and single-cell transcriptional profiling were employed.
• Functional assays assessed cytotoxicity, cytokine production, and cellular activation markers.

Main Results:

• A distinct CD56+CD20+ NK cell subset was identified, exhibiting activated phenotypes (NKp46, CD69, CD137).
• These cells demonstrated heightened cytotoxicity, cytokine secretion (IFN-γ, GM-CSF, TNF-α, IL-10), and expressed increased cytolytic mediators.
• Single-cell profiling revealed a unique molecular signature with elevated granzyme K and memory-like features.
• CD20+ NK cells were found enriched in secondary lymphoid organs, inflammatory tissues, and various inflammatory conditions (e.g., multiple sclerosis, cancers).

Conclusions:

• CD20+ NK cells represent a functionally distinct lymphocyte subset with potent effector capabilities and tissue-homing properties.
• Their enrichment in inflammatory conditions highlights their role in immune regulation and disease pathogenesis.
• The depletion of CD20+ NK cells by rituximab suggests potential therapeutic strategies for inflammatory diseases.